3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies
暂无分享,去创建一个
[1] V. Lennon,et al. Muscle specific kinase autoimmune myasthenia gravis in children: A case series , 2013, Neuromuscular Disorders.
[2] K. Toyka,et al. Pyridostigmine but not 3,4‐diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle‐specific kinase autoantibody , 2013, The Journal of physiology.
[3] K. Shigemoto,et al. 3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis , 2012, Journal of Neuroimmunology.
[4] A. Masuda,et al. Anti-MuSK autoantibodies block binding of collagen Q to MuSK , 2011, Neurology.
[5] D. Sanders,et al. Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis. , 2010, Current opinion in neurology.
[6] De-Pei Li,et al. Aminopyridines Potentiate Synaptic and Neuromuscular Transmission by Targeting the Voltage-activated Calcium Channel β Subunit*♦ , 2009, The Journal of Biological Chemistry.
[7] Changing the "channel": aminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit. , 2009, The Journal of biological chemistry.
[8] R. Flink,et al. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody , 2006, Muscle & nerve.
[9] S. Oh,et al. Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG , 2005, Neurology.
[10] P. Tonali,et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. , 2003, Brain : a journal of neurology.